Clinical efficacy and security of glycyrrhizic acid preparation in the treatment of anti-SARS-CoV-2 drug-induced liver injury: a protocol of systematic review and meta-analysis

INTRODUCTION: COVID-19 is a highly infectious acute pneumonia. Glycyrrhizic acid preparation (GAP) has been found to have hepatoprotective and antiviral effects, but there is no supporting evidence on its efficacy and security for patients with COVID-19. METHODS AND ANALYSIS: The systematic review m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xia, Gan, Wenfan, Nie, Yisen, Ying, Rongtao, Tan, Yongji, Chen, Junli, Chen, Mei, Zhang, Chuantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275357/
https://www.ncbi.nlm.nih.gov/pubmed/34244286
http://dx.doi.org/10.1136/bmjopen-2021-051484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275357/
https://www.ncbi.nlm.nih.gov/pubmed/34244286
http://dx.doi.org/10.1136/bmjopen-2021-051484

Ejemplares similares